Date: December 6-9, 2003
Location: San Diego, CA
The content presented here was prepared by independent authors under the editorial supervision of OncoEd and is not endorsed or sanctioned by the American Society of Hematology.
Conference Summaries
Monoclonal Antibody Therapy for B-Cell Malignancies: Update from ASH
ASH 2003 Anemia Review
Advances in the Treatment of Mucositis
Author: Co-Author: Charles H. Weaver M.D. Co-Author: Dayna Deuter
Treatment of Multiple Myeloma
There have been significant therapeutic developments over the past decade in the treatment of patients with multiple myeloma. At ASH 2003, two groups from the University of Arkansas and the Royal Marsden Hospital reported improved survival over time for patients treated sequentially for multiple myeloma.
Stem Cell Transplants for the Treatment of Multiple Myeloma
Over the past decade or more, autologous transplants following remission induction have been shown to prolong survival when compared to continued chemotherapy for the treatment of multiple myeloma.
ASH 2003 Update: Cellular Therapies
Maximum results may have already been achieved with conventional and high-dose chemotherapy for diseases such as acute myeloid leukemia, multiple myeloma and the lymphomas.
Patient Home
2008 Coverage
